Stantech Pharmaceuticals Private Limited, a active private limited company, was established on 26 May 2005 in Mumbai, Maharashtra, India. Engaging in it products retail & distribution within the trade sector, it holds CIN: U24230MH2005PTC153516. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹75.01 K .
It upholds a compliant status. Employing 24 professional, Its leadership includes Pankaj Rajkumar Yambal (Director), Rohit Rajkumar Yambal (Director), Swati Pankaj Jain (Additional Director). Past directors included Sameer Ashok Paigankar, Pankaj Rajkumar Yambal, Rohit Rajkumar Yambal. It holds ₹12.44 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Office No-3 To 6, 7Th Floor Arcadia Building , 195 Ncpa Marg, Narima, N Point, Mumbai, Maharashtra, 400021.
U24230MH2005PTC153516
153516
26 May 2005
₹1.00 M
₹75.01 K
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Stantech Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pankaj Rajkumar Yambal | Director | 01 Apr 2019 | Current |
| Rohit Rajkumar Yambal | Director | 01 Apr 2019 | Current |
| Swati Pankaj Jain | Additional Director | 18 Dec 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 11 Jul 2019 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Director | 11 Jul 2019 | Past |
| Pramod Abcsdd | Director | 11 Jul 2019 | Past |
| Pramod Abcsdd | Director | 07 Nov 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Stantech Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 65.77% increase. The company also saw a substantial fall in profitability, with a 306.98% decrease in profit. The company's net worth observed a substantial decline by a decrease of 22.27%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Stantech Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹124,400,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Apr 2021 | Others | ₹12.44 Cr | Open |
Explore comprehensive loan charge details -
Stantech Pharmaceuticals has a workforce of 24 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Stantech Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stantech Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others of Rs. 124.40 M registered on 08 Apr 2021 with Charge ID 100447427 was modified on 12 Dec 2024. was recorded as a recent event.
Stantech Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Stantech Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
The activity Swati Pankaj Jain was appointed as a Additional Director was appointed as a Additional Director on 18 Dec 2021 & has been associated with this company since 3 years 11 months . was completed.
The activity A charge with Others amounted to Rs. 124.40 M with Charge ID 100447427 was registered on 08 Apr 2021. was completed.
The activity Pankaj Rajkumar Yambal was appointed as a Director was appointed as a Director on 01 Apr 2019 & has been associated with this company since 6 years 8 months . was completed.
The CIN of Stantech Pharmaceuticals Private Limited is U24230MH2005PTC153516.
Stantech Pharmaceuticals Private Limited is headquartered at Office No-3 To 6, 7Th Floor Arcadia Building , 195 Ncpa Marg, Narima, N Point, Mumbai, Maharashtra, 400021.
Stantech Pharmaceuticals Private Limited was incorporated on 26 May 2005.
The current directors of Stantech Pharmaceuticals Private Limited are
The primary industry of Stantech Pharmaceuticals Private Limited is Trade.
Stantech Pharmaceuticals Private Limited is unlisted.
The authorized capital of Stantech Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹75.01 K .
The compliance status of Stantech Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX